We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial (275778)
ARTG ID 275778
ARTG Name
OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial
Product name
OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Sponsor
Ingredients
ocrelizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information